Skip to main content

Table 3 HPV type prevalence according to age group and anatomical site

From: Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy

 

< 25 (%)*

26–30 (%)*

31–35 (%)*

36–40 (%)*

41–45 (%)*

46–50 (%)*

51–55 (%)*

> 56 (%)*

Total (%)

HRHPV (cervical)

64.3

61.5

45.5

80.0

52.2

30

42.9

44.4

55.1

LRHPV (cervical)

28.6

23.1

18.2

15.0

21.7

10.0

14.3

22.2

19.5

HRHPV (anal)

28.6

76.9

50.0

75.0

52.2

50.0

57.1

33.3

54.2

LRHPV (anal)

21.4

46.2

27.3

30.0

21.7

30.0

28.6

33.3

28.8

HRHPV (oral)

0.0

0.0

0.0

5.0

8.7

0.0

0.0

0.0

2.5

LRHPV (oral)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

9HPV (cervical)

42.9

46.2

40.9

75.0

47.8

30.0

42.9

33.3

47.5

9HPV (anal)

14.3

69.2

36.4

70.0

52.2

40.0

14.3

22.2

44.1

9HPV (oral)

0.0

0.0

0.0

5.0

4.3

0.0

0.0

0.0

1.7

  1. HRHPV high-risk human papillomavirus, LRHPV low-risk human papillomavirus, 9HPV human papillomaviruses targeted by the nonavalent HPV vaccine
  2. *Percentages refer to the total of each age group